Panagora Asset Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Panagora Asset Management’s Portfolio VYNT Stock Details VYNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-249	Closed	-$9K	–	2596
2018 Q4	$9K	Sell	249 -5	-2%	-$421	﹤0.01%	2336
2018 Q3	$40K	Sell	254 -37	-13%	-$5.48K	﹤0.01%	2068
2018 Q2	$39K	Buy	+291	New	+$44K	﹤0.01%	2088
2017 Q3	–	Sell	-43	Closed	-$25K	–	2546
2017 Q2	$25K	Sell	43 -238	-85%	-$139K	﹤0.01%	2220
2017 Q1	$173K	Hold	281	–	–	﹤0.01%	1702
2016 Q4	$57K	Hold	281	–	–	﹤0.01%	2074
2016 Q3	$74K	Buy	+281	New	+$86.1K	﹤0.01%	2040

Other funds holding VYNT

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Fairbanks Capital Management Rancho Santa Fe, California $169M AUM 12.21% 1-Year Est. Return

Diker Management New York $130M AUM 97.77% 1-Year Est. Return

FPB

First PREMIER Bank Sioux Falls, South Dakota $619M AUM 20.21% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Panagora Asset Management's VYNT Position: Q1 2019 in Review

Panagora Asset Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2019, closing a stake of 249 shares — an estimated $9K sold.

Panagora Asset Management first reported a position in VYNT in Q3 2016 and held it in 7 quarters. The position peaked at $173K in Q1 2017. 24 funds tracked by Wall St. Rank hold VYNT as of Q1 2019.

Panagora Asset Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Panagora Asset Management sold 249 Vyant Bio, Inc. Common Stock shares in Q1 2019, an estimated $9K.
Panagora Asset Management first reported a position in Vyant Bio, Inc. Common Stock in Q3 2016 and held it in 7 quarters.
Panagora Asset Management's Vyant Bio, Inc. Common Stock position peaked at $173K in Q1 2017.
24 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2019.

Based on Panagora Asset Management's 13F filing for Q1 2019, filed 15 May 2019.